EUVIMEDEUVIMED entdecken
Crossref

LTBP4 deficiency induces MRC1 + /CD44 + macrophages to drive cancer progression in preclinical colorectal cancer models

Songtao Ji iD, Shuya Du iD, Ge Miao iD, Xiaohua Yang iD, Haojia Wang iD, Xuemei Li iD, Wanqi Ma, Dan Wei, Tianyu Cao iD, Mingzhen Zhou, Jianing Yu, Xiangshu Cheng und 9 weitere

Science Translational Medicine · 2026

DOI: 10.1126/scitranslmed.aeb2189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Songtao Ji und 20 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing…. Hauptthemen laut MEDLINE: Latent TGF-beta Binding Proteins, Colorectal Neoplasms, Disease Progression, Macrophages. Die Arbeit nennt 80 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shaanxi Innovation Capability Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment is crucial for cancer progression, but the mechanisms underlying the tumor-immune cell interactions in it remain poorly understood. Here, we identified latent transforming growth factor–β (TGFβ) binding protein 4 (LTBP4) deficiency in colorectal cancer (CRC) as a critical driver that reprogrammed tumor-associated macrophages (TAMs) and induced a distinct subset, which promoted tumor progression by coordinating immune evasion and extracellular matrix (ECM) remodeling. Clinically, LTBP4 deficiency correlated with CRC progression and poor patient survival. Ltbp4 knockout markedly promoted tumor growth and metastasis in immunocompetent mice, an effect attenuated in immunodeficient hosts, establishing the essential role of host immunity in mediating the effects of LTBP4 deficiency. Single-cell RNA sequencing revealed that LTBP4 deficiency induced a mannose receptor C-type 1–positive (MRC1 + )/CD44 + TAM subset and correlated with reduced CD8 + T cell infiltration. Mechanistically, LTBP4 deficiency increased active TGFβ1 levels, which acted in a paracrine manner to up-regulate MRC1 in TAMs, whereas autocrine signaling induced HAS2 (hyaluronan synthase 2) expression and hyaluronan production to increase CD44. CD44 signaling in TAMs up-regulated matrix metalloproteinases for collagen degradation, whereas MRC1 mediated collagen internalization, cooperatively remodeling the ECM to facilitate tumor invasion. The TGFβ1-driven MRC1 + /CD44 + TAMs further suppressed CD8 + T cell function by diminishing the C-X-C motif chemokine ligand 16-C-X-C motif chemokine receptor 6 (CXCL16-CXCR6) axis. Therapeutically, targeted depleting MRC1 + /CD44 + TAMs enhanced the efficacy of PD-1 (programmed cell death–1) blockade in LTBP4-deficient tumors. Our study positions LTBP4 as a key modulator of tumor progression and reveals a therapeutic strategy for LTBP4-deficient CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Latent TGF-beta Binding ProteinsColorectal NeoplasmsDisease ProgressionMacrophagesHyaluronan ReceptorsAnimalsHumansDisease Models, AnimalTransforming Growth Factor beta1MiceCell Line, TumorMice, KnockoutTumor MicroenvironmentExtracellular MatrixSignal TransductionMice, Inbred C57BL

Substanzen

Latent TGF-beta Binding ProteinsHyaluronan ReceptorsTransforming Growth Factor beta1LTBP4 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032,…
  • Department of Gastroenterology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, China.
  • Department of Experimental Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
  • Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
  • School of Medicine, Northwest University, Xi'an, Shaanxi 710069, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.

ORCID-Profile: Songtao Ji, Shuya Du, Ge Miao, Xiaohua Yang, Haojia Wang, Xuemei Li, Tianyu Cao, Hongyan Qin, Liang Wang, Xin Wang, Yuanyuan Lu, Xiaodi Zhao

Förderung

  • National Natural Science Foundation of China
  • Shaanxi Innovation Capability Support Program

Zitieren

APA

Ji, S., Du, S., Miao, G., Yang, X., Wang, H., Li, X., Ma, W., Wei, D., Cao, T., Zhou, M., Yu, J., Cheng, X., Zhang, Y., Han, H., Nie, Y., Li, J., Qin, H., Wang, L., Wang, X., …, & Zhao, X. (2026). LTBP4 deficiency induces MRC1 + /CD44 + macrophages to drive cancer progression in preclinical colorectal cancer models. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aeb2189

Vancouver

Ji S, Du S, Miao G, Yang X, Wang H, Li X, et al. LTBP4 deficiency induces MRC1 + /CD44 + macrophages to drive cancer progression in preclinical colorectal cancer models. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aeb2189

BibTeX
@article{Ji2026,
  author = {Ji, Songtao and Du, Shuya and Miao, Ge and Yang, Xiaohua and Wang, Haojia and Li, Xuemei and Ma, Wanqi and Wei, Dan and Cao, Tianyu and Zhou, Mingzhen and Yu, Jianing and Cheng, Xiangshu and Zhang, Yuanci and Han, Hua and Nie, Yongzhan and Li, Jipeng and Qin, Hongyan and Wang, Liang and Wang, Xin and Lu, Yuanyuan and Zhao, Xiaodi},
  title = {LTBP4 deficiency induces MRC1 + /CD44 + macrophages to drive cancer progression in preclinical colorectal cancer models},
  journal = {Science Translational Medicine},
  year = {2026},
  doi = {10.1126/scitranslmed.aeb2189}
}
Kostenlos starten →